Doxorubicin, Liposomal Solution For Injection 2Mg Drug Medication Dosage Information
show timeout overlay link

Your Session Is About to Expire

This online session is about to expire due to inactivity. Click Continue to return to page.

  • myWeekly Ad

Doxorubicin, Liposomal: Solution for injection (2mg)

Also see:
  • Get answers to Frequently Asked Questions (FAQs)
  • Find other class related drugs
  • Find additional patient usage statistics

Visit Drug Summary Page
Drug Image file default-drug-image.png


What is this Medicine?

LIPOSOMAL DOXORUBICIN (LIP oh som al dox oh ROO bi sin) is a chemotherapy drug. This medicine is used to treat many kinds of cancer like Kaposi's sarcoma, multiple myeloma, and ovarian cancer.

Similar Brand Name Drugs : Doxil: Solution for injection (2mg)
In-Depth Information
Select a Medication

Doxorubicin Hydrochloride 20mg/10ml Liposomal Injection

NDC: 473350049
  • Prescription Required
  • Not a Controlled Drug
    (CSA Schedule)
  • FDA Approved




FDA approved for the following conditions:
Multiple Myeloma, Ovarian Cancer, Kaposi's Sarcoma

Sometimes used for but not FDA approved for the following conditions:
Breast Cancer, Mycosis Fungoides, Cutaneous T-cell Lymphoma (CTCL)

Storage Information
Store unreconstituted product in refrigerator (36 to 46 degrees F)
Discard product if it contains particulate matter, is cloudy, or discolored
Store in carton until time of use
Protect from freezing
Doxorubicin Hydrochloride 20mg/10ml Liposomal Injection

Reported Side Effects for Doxorubicin Hydrochloride 20mg/10ml Liposomal Injection

Irritated Blood Vessels Incidence:
<1.0%*
Severity: MODERATE
Onset: RAPID
Paresthesias Incidence:
<1.0%*
Severity: SEVERE
Onset: DELAYED
Hand And Foot Syndrome Incidence:
<24.0%*
Severity: SEVERE
Onset: DELAYED
Sore Throat Incidence:
<16.0%*
Severity: MILD
Onset: DELAYED
Abnormal Heart Rhythm Incidence:
<1.0%*
Severity: MODERATE
Onset: EARLY
Rash With Pustules Incidence:
<10.0%*
Severity: MILD
Onset: EARLY
Stevens-Johnson Syndrome Incidence:
<1.0%*
Severity: SEVERE
Onset: DELAYED
Rapid Heart Rate Incidence:
<1.0%*
Severity: SEVERE
Onset: EARLY
Rapid Heart Rate Incidence:
<1.0%*
Severity: SEVERE
Onset: EARLY
Stomach Pain Incidence:
<1.0%*
Severity: SEVERE
Onset: EARLY
Dysesthesia Incidence:
<1.0%*
Severity: SEVERE
Onset: DELAYED
Bundle-branch Block Incidence:
<1.0%*
Severity: MODERATE
Onset: EARLY
Liver Infection Incidence:
<1.0%*
Severity: MODERATE
Onset: DELAYED
Nerve Pain Incidence:
<7.0%*
Severity: SEVERE
Onset: DELAYED
Vomiting Incidence:
<8.0%*
Severity: SEVERE
Onset: EARLY
Secondary Malignancy Incidence:
<1.0%*
Severity: MODERATE
Onset: DELAYED
Infusion-related Reactions Incidence:
<11.0%*
Severity: MODERATE
Onset: RAPID
Weakness Incidence:
<7.0%*
Severity: SEVERE
Onset: DELAYED
Upset Stomach Incidence:
<5.0%*
Severity: SEVERE
Onset: EARLY
Decreased Appetite Incidence:
<2.5%*
Severity: SEVERE
Onset: DELAYED
Weakness Incidence:
<7.0%*
Severity: SEVERE
Onset: EARLY
Suddenly Stopped Heart Incidence:
<10.0%*
Severity: SEVERE
Onset: EARLY
Heart Muscle Disease Incidence:
<11.0%*
Severity: SEVERE
Onset: DELAYED
Constipation Incidence:
<1.0%*
Severity: SEVERE
Onset: DELAYED
Cough Incidence:
<18.0%*
Severity: MILD
Onset: DELAYED
Lyell'S Syndrome Incidence:
<1.0%*
Severity: SEVERE
Onset: DELAYED
Blood Clot Incidence:
<10.0%*
Severity: SEVERE
Onset: DELAYED
Rapid Heart Rate Incidence:
<1.0%*
Severity: MODERATE
Onset: EARLY
Upset Stomach Incidence:
<0.8%*
Severity: SEVERE
Onset: EARLY
Radiation Recall Reaction Incidence:
<1.0%*
Severity: MODERATE
Onset: DELAYED
Superinfection Incidence:
<1.0%*
Severity: MODERATE
Onset: DELAYED
Erythema Multiforme Incidence:
<1.0%*
Severity: SEVERE
Onset: DELAYED
Heart Failure Incidence:
<2.0%*
Severity: SEVERE
Onset: DELAYED
Headache Incidence:
<0.8%*
Severity: SEVERE
Onset: EARLY
Tired Incidence:
<7.0%*
Severity: SEVERE
Onset: EARLY
Anemia Incidence:
0.4-16.0%*
Severity: SEVERE
Onset: DELAYED
Fever Incidence:
0.8-1.0%*
Severity: SEVERE
Onset: EARLY
Blistery Rash Incidence:
1.0-10.0%*
Severity: MODERATE
Onset: EARLY
Weight Loss Incidence:
1.0-10.0%*
Severity: MILD
Onset: DELAYED
Skin Rash Incidence:
1.0-4.2%*
Severity: SEVERE
Onset: EARLY
Peripheral Vasodilation Incidence:
1.0-10.0%*
Severity: MODERATE
Onset: RAPID
Rhinitis Incidence:
1.0-10.0%*
Severity: MILD
Onset: EARLY
Chest Pain Incidence:
1.0-5.0%*
Severity: MODERATE
Onset: EARLY
Vesicular Rash Incidence:
1.0-10.0%*
Severity: MILD
Onset: DELAYED
Conjunctivitis Incidence:
1.0-10.0%*
Severity: MODERATE
Onset: DELAYED
Lightheadedness Incidence:
1.0-10.0%*
Severity: MILD
Onset: EARLY
Mouth Sores Incidence:
1.0-10.0%*
Severity: MODERATE
Onset: DELAYED
Rapid Heart Rate Incidence:
1.0-10.0%*
Severity: MODERATE
Onset: RAPID
Skin Discoloration Incidence:
1.0-10.0%*
Severity: MILD
Onset: DELAYED
Metallic Taste Incidence:
1.0-10.0%*
Severity: MILD
Onset: EARLY
Bruise Incidence:
1.0-10.0%*
Severity: MILD
Onset: DELAYED
Elevated Hepatic Enzymes Incidence:
1.0-5.0%*
Severity: MODERATE
Onset: DELAYED
Acne Incidence:
1.0-10.0%*
Severity: MILD
Onset: DELAYED
Yeast Infection Incidence:
1.0-10.0%*
Severity: MODERATE
Onset: DELAYED
Dehydration Incidence:
1.0-10.0%*
Severity: MODERATE
Onset: DELAYED
Depression Incidence:
1.0-10.0%*
Severity: MODERATE
Onset: DELAYED
Drowsiness Incidence:
1.0-10.0%*
Severity: MILD
Onset: EARLY
Nose Bleed Incidence:
1.0-10.0%*
Severity: MILD
Onset: DELAYED
Throat Inflammation Incidence:
1.0-10.0%*
Severity: MODERATE
Onset: DELAYED
Exfoliative Dermatitis Incidence:
1.0-10.0%*
Severity: SEVERE
Onset: DELAYED
Boils Incidence:
1.0-10.0%*
Severity: MODERATE
Onset: DELAYED
High Bilirubin Level Incidence:
1.0-10.0%*
Severity: MODERATE
Onset: DELAYED
High Calcium Levels Incidence:
1.0-10.0%*
Severity: MODERATE
Onset: DELAYED
Low Potassium Levels Incidence:
1.0-10.0%*
Severity: MODERATE
Onset: DELAYED
Low Blood Sodium Levels Incidence:
1.0-10.0%*
Severity: MODERATE
Onset: DELAYED
Low Blood Pressure Incidence:
1.0-10.0%*
Severity: MODERATE
Onset: RAPID
Bowel Obstruction Incidence:
1.0-10.0%*
Severity: SEVERE
Onset: DELAYED
Itching Incidence:
1.0-10.0%*
Severity: MILD
Onset: RAPID
Sinus Infection Incidence:
1.0-10.0%*
Severity: MILD
Onset: DELAYED
Dry Eyes Incidence:
1.0-10.0%*
Severity: MILD
Onset: EARLY
Dry Skin Incidence:
1.0-10.0%*
Severity: MILD
Onset: DELAYED
Bleeding Incidence:
1.0-10.0%*
Severity: MODERATE
Onset: EARLY
Difficulty Swallowing Incidence:
1.0-10.0%*
Severity: MODERATE
Onset: DELAYED
Blood In The Urine Incidence:
1.0-10.0%*
Severity: MODERATE
Onset: DELAYED
Back Pain Incidence:
1.0-11.7%*
Severity: MILD
Onset: DELAYED
Low Platelet Count Incidence:
1.3-24.0%*
Severity: SEVERE
Onset: DELAYED
Mouth Ulcers Incidence:
2.0-8.0%*
Severity: SEVERE
Onset: DELAYED
Infection Incidence:
2.1%*
Severity: SEVERE
Onset: DELAYED
Loose Stools Incidence:
2.5-7.0%*
Severity: SEVERE
Onset: EARLY
Hair Loss Incidence:
9.0-19.0%*
Severity: MILD
Onset: DELAYED
Low White Blood Cells Incidence:
12.2-49.0%*
Severity: SEVERE
Onset: DELAYED
*This is an approximate aggregated range of reported side effects from clinical studies performed on this drug. Your experience with this drug may be different.
Pregnancy & Lactation Information
Lactation

Avoid - This drug is known to cause harm to infants when taken by nursing mothers.


Learning More About
Visit the Drug Summary page where you can:
  • Get answers to Frequently Asked Questions (FAQs)
  • Find other class related drugs
  • Find additional patient usage statistics
Learn More
Patient Experiences with Doxorubicin, Liposomal

Be the first to share your experience!

We want to help our customers stay educated about the medications they are taking. Submit your own observations and experiences to benefit others.

Average Scores
Easy to Take 
0 / 5
0 / 5
Works as Intended 
0 / 5
0 / 5
Tolerable 
0 / 5
0 / 5